BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28542879)

  • 1. The catalase gene promoter and 5'-untranslated region variants lead to altered gene expression and enzyme activity in vitiligo.
    Mansuri MS; Jadeja SD; Singh M; Laddha NC; Dwivedi M; Begum R
    Br J Dermatol; 2017 Dec; 177(6):1590-1600. PubMed ID: 28542879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo susceptibility and catalase gene polymorphisms in Sicilian population.
    Caputo V; Niceta M; Fiorella S; La Vecchia M; Bastonini E; Bongiorno MR; Pistone G
    G Ital Dermatol Venereol; 2018 Oct; 153(5):619-623. PubMed ID: 28206724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between catalase (CAT) gene polymorphisms and susceptibility to vitiligo in a Turkish population.
    Akbas H; Dertlioglu SB; Dilmec F; Balkan M
    Clin Ter; 2013; 164(3):e173-7. PubMed ID: 23868633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
    Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
    Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
    Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter variant in the catalase gene is associated with vitiligo in Chinese people.
    Liu L; Li C; Gao J; Li K; Zhang R; Wang G; Li C; Gao T
    J Invest Dermatol; 2010 Nov; 130(11):2647-53. PubMed ID: 20613769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of oxidative stress status, catalase and catechol-O-methyltransferase polymorphisms in Egyptian vitiligo patients.
    Mehaney DA; Darwish HA; Hegazy RA; Nooh MM; Tawdy AM; Gawdat HI; El-Sawalhi MM
    PLoS One; 2014; 9(6):e99286. PubMed ID: 24915010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population.
    Park HH; Ha E; Uhm YK; Jin SY; Kim YJ; Chung JH; Lee MH
    Exp Dermatol; 2006 May; 15(5):377-80. PubMed ID: 16630078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between catalase gene polymorphism (T/C exon 9) and susceptibility to vitiligo in a Turkish population.
    Bulut H; Pehlivan M; Alper S; Tomatir AG; Onay H; Yüksel SE; Ozkinay F; Pehlivan S
    Genet Mol Res; 2011 Oct; 10(4):4126-32. PubMed ID: 22058000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
    Giri PS; Patel S; Begum R; Dwivedi M
    Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
    Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of
    Saif GAB; Alshammary AF; Ali Khan I
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109666
    [No Abstract]   [Full Text] [Related]  

  • 14. Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo.
    Laddha NC; Dwivedi M; Gani AR; Shajil EM; Begum R
    Free Radic Biol Med; 2013 Dec; 65():1110-1125. PubMed ID: 24036105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population.
    Kim TH; Hong JM; Oh B; Cho YS; Lee JY; Kim HL; Shin ES; Lee JE; Park EK; Kim SY
    Osteoarthritis Cartilage; 2008 Sep; 16(9):1060-6. PubMed ID: 18353692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymorphism of catalase T/C codon 389 in exon 9 and vitiligo susceptibility: a meta-analysis.
    Lv YJ; Liao WJ; Luan Q; Wang H; Wang L; Li Q
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):955-8. PubMed ID: 21054578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of catalase gene polymorphisms with catalase activity and susceptibility to systemic lupus erythematosus in the Suez Canal area, Egypt.
    Ghaly MS; Ghattas MH; Labib SM
    Lupus; 2012 Oct; 21(11):1244-9. PubMed ID: 22736749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat.
    Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R
    PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalase -262C>T polymorphisms in Hungarian vitiligo patients and in controls: further acatalasemia mutations in Hungary.
    Kósa Z; Fejes Z; Nagy T; Csordás M; Simics E; Remenyik E; Góth L
    Mol Biol Rep; 2012 Apr; 39(4):4787-95. PubMed ID: 21947853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of the catalase gene (CAT) with vitiligo susceptibility.
    Casp CB; She JX; McCormack WT
    Pigment Cell Res; 2002 Feb; 15(1):62-6. PubMed ID: 11837458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.